Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
KRON
|
Joshua A Kazam |
BUY
Bona fide gift
|
Direct | 211,000 Added 40.85% |
-
|
Mar 07
2022 |
ATIP
|
Diana Chafey |
BUY
Grant, award, or other acquisition
|
Direct | 71,839 Added 23.45% |
-
|
Mar 07
2022 |
DDD
|
Charles W Hull
EVP & Chief Technology Officer |
SELL
Open market or private sale
|
Indirect | 16,389 Reduced 3.53% |
$242,229
$14.78 p/Share
|
Mar 07
2022 |
SGFY
|
Laurel Douty
EVP, Clinic. Ops, Care Srvces |
BUY
Grant, award, or other acquisition
|
Direct | 44,046 Added 44.9% |
-
|
Mar 07
2022 |
OVV
|
Corey Douglas Code
EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 11,824 Reduced 20.15% |
$546,387
$46.21 p/Share
|
Mar 07
2022 |
OVV
|
Corey Douglas Code
EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 24,633 Added 29.56% |
-
|
Mar 07
2022 |
OVV
|
Renee Ellen Zemljak |
SELL
Payment of exercise price or tax liability
|
Direct | 14,267 Reduced 21.04% |
$666,412
$46.71 p/Share
|
Mar 07
2022 |
OVV
|
Renee Ellen Zemljak |
BUY
Exercise of conversion of derivative security
|
Direct | 32,499 Added 32.4% |
-
|
Mar 07
2022 |
APA
|
P Anthony Lannie
Exec. Vice Pres & Gen Counsel |
SELL
Open market or private sale
|
Direct | 40,800 Reduced 21.89% |
$1,627,920
$39.9 p/Share
|
Mar 07
2022 |
APA
|
P Anthony Lannie
Exec. Vice Pres & Gen Counsel |
BUY
Discretionary transaction
|
Indirect | 40,800 Added 50.0% |
$1,646,688
$40.36 p/Share
|
Mar 07
2022 |
CNSP
|
John M Climaco
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 35,000 Added 3.59% |
$9,800
$0.28 p/Share
|
Mar 07
2022 |
KBNT
|
Mithaq Capital Spc |
BUY
Open market or private purchase
|
Indirect | 63,684 Added 1.85% |
$114,631
$1.8 p/Share
|
Mar 07
2022 |
KBNT
|
Mithaq Capital Spc |
BUY
Open market or private purchase
|
Direct | 31,872 Added 1.85% |
$57,370
$1.8 p/Share
|
Mar 07
2022 |
MYO
|
Harry Kovelman
Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 131 Reduced 0.64% |
$946
$7.22 p/Share
|
Mar 07
2022 |
ENSV
|
William A Jolly
Director |
BUY
Grant, award, or other acquisition
|
Direct | 35,170 Added 29.86% |
-
|
Mar 07
2022 |
ENSV
|
Robert S Herlin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 35,170 Added 29.77% |
-
|
Mar 07
2022 |
TYME
|
Michael Demurjian
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.08% |
$5,800
$0.29 p/Share
|
Mar 07
2022 |
VRAR
|
Alexander Ruckdaeschel
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 33.33% |
$5,130
$5.13 p/Share
|
Mar 07
2022 |
LMPX
|
Samer Tawfik
President and CEO |
SELL
Open market or private sale
|
Indirect | 9,000 Reduced 0.9% |
$33,750
$3.75 p/Share
|
Mar 07
2022 |
MLSS
|
Leonard Osser
Director |
SELL
Open market or private sale
|
Direct | 6,400 Reduced 0.15% |
$9,792
$1.53 p/Share
|
Mar 07
2022 |
AFBI
|
Howard G Roberts
Director |
BUY
Open market or private purchase
|
Direct | 3,000 Added 12.6% |
$45,750
$15.25 p/Share
|
Mar 07
2022 |
MFIN
|
Thomas J. Munson |
BUY
Open market or private purchase
|
Indirect | 1,100 Added 24.19% |
$9,405
$8.55 p/Share
|
Mar 07
2022 |
OPBK
|
Ock Hee Kim
Director |
BUY
Open market or private purchase
|
Direct | 33,200 Added 5.64% |
$434,920
$13.1 p/Share
|
Mar 07
2022 |
WMPN
|
Christopher Matthew Molden |
BUY
Open market or private purchase
|
Indirect | 1,030 Added 50.0% |
$12,659
$12.29 p/Share
|
Mar 07
2022 |
NIOBF
|
Neal S. Shah
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 140,170 Reduced 27.21% |
$116,341
$0.83 p/Share
|
Mar 07
2022 |
NIOBF
|
Neal S. Shah
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 195,500 Added 27.51% |
$117,300
$0.6 p/Share
|
Mar 07
2022 |
FDEU
|
M Keefe Denise
Director |
BUY
Open market or private purchase
|
Direct | 750 Added 33.33% |
$8,663
$11.55 p/Share
|
Mar 07
2022 |
TBNK
|
Allan S Kitagawa
Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,054 Reduced 0.67% |
$26,160
$24.82 p/Share
|
Mar 07
2022 |
TBNK
|
Vernon Hirata
Vice Chairman & Co-COO |
SELL
Payment of exercise price or tax liability
|
Direct | 371 Reduced 0.44% |
$9,208
$24.82 p/Share
|
Mar 07
2022 |
TBNK
|
Ralph Y Nakatsuka
Vice Chairman & Co-COO |
SELL
Payment of exercise price or tax liability
|
Direct | 377 Reduced 0.24% |
$9,357
$24.82 p/Share
|
Mar 07
2022 |
OBT
|
Michael Lesler
EVP, Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect | 1,000 Added 50.0% |
$41,000
$41.0 p/Share
|
Mar 07
2022 |
ISTR
|
John J D'Angelo
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 200 Added 0.11% |
$3,986
$19.93 p/Share
|
Mar 07
2022 |
EVER
|
David Brainard
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 4.96% |
$84,000
$12.0 p/Share
|
Mar 07
2022 |
BRBS
|
Vance H Spilman |
BUY
Open market or private purchase
|
Direct | 3,000 Added 11.94% |
$46,230
$15.41 p/Share
|
Mar 07
2022 |
FFA
|
M Keefe Denise
Director |
BUY
Open market or private purchase
|
Direct | 250 Added 25.0% |
$4,875
$19.5 p/Share
|
Mar 07
2022 |
CARE
|
Wendy S. Bell
SENIOR EXECUTIVE VP, CFO |
BUY
Grant, award, or other acquisition
|
Direct | 2,437 Added 9.68% |
-
|
Mar 07
2022 |
CARE
|
Litz H Van Dyke
CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 6,373 Added 17.98% |
-
|
Mar 07
2022 |
CARE
|
Tony E Kallsen
SEVP, CHIEF CREDIT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 2,437 Added 24.26% |
-
|
Mar 07
2022 |
CARE
|
Bradford N. Langs
PRESIDENT, CHIEF STRATEGY OFCR |
BUY
Grant, award, or other acquisition
|
Direct | 2,812 Added 22.44% |
-
|
Mar 07
2022 |
CARE
|
Matthew M. Speare
SEVP, CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 2,437 Added 9.2% |
-
|
Mar 07
2022 |
CVEO
|
Allan Schoening
SVP, Canada |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 18.23% |
$116,850
$23.37 p/Share
|
Mar 07
2022 |
CCNE
|
Joel E. Peterson
Director |
BUY
Open market or private purchase
|
Direct | 4,507 Added 18.09% |
$116,236
$25.79 p/Share
|
Mar 07
2022 |
MITK
|
Scott Adam Marcus
General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 42,950 Added 50.0% |
-
|
Mar 07
2022 |
VUZI
|
Paul J Travers
President and CEO |
BUY
Open market or private purchase
|
Direct | 1,500 Added 0.05% |
$8,460
$5.64 p/Share
|
Mar 07
2022 |
EZPW
|
Matthew Appel
Director |
BUY
Grant, award, or other acquisition
|
Direct | 26,490 Added 12.5% |
$160,000
$6.04 p/Share
|
Mar 07
2022 |
EZPW
|
Gary Tillett
Director |
BUY
Grant, award, or other acquisition
|
Direct | 26,490 Added 19.74% |
$160,000
$6.04 p/Share
|
Mar 07
2022 |
EZPW
|
Zena Srivatsa Arnold
Director |
BUY
Grant, award, or other acquisition
|
Direct | 26,490 Added 19.74% |
$160,000
$6.04 p/Share
|
Mar 07
2022 |
EZPW
|
Pablo Lagos Espinosa
Director |
BUY
Grant, award, or other acquisition
|
Direct | 26,490 Added 10.96% |
$160,000
$6.04 p/Share
|
Mar 07
2022 |
EZPW
|
Jason A. Kulas
Director |
BUY
Grant, award, or other acquisition
|
Direct | 26,490 Added 15.86% |
$160,000
$6.04 p/Share
|
Mar 07
2022 |
CPSI
|
Amaris Angelica Mc Comas
Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct | 4,878 Added 30.08% |
-
|
Mar 07
2022 |